MENU
+Compare
RDY
Stock ticker: NYSE
AS OF
Feb 4, 04:13 PM (EDT)
Price
$14.03
Change
+$0.21 (+1.52%)
Capitalization
11.35B

RDY Dr. Reddy's Laboratories Ltd Forecast, Technical & Fundamental Analysis

RDY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for RDY with price predictions
Feb 03, 2026

RDY in -3.21% downward trend, falling for three consecutive days on January 29, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where RDY declined for three days, in of 267 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The 10-day moving average for RDY crossed bearishly below the 50-day moving average on January 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

The Aroon Indicator for RDY entered a downward trend on January 29, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where RDY's RSI Indicator exited the oversold zone, of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on January 30, 2026. You may want to consider a long position or call options on RDY as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for RDY just turned positive on January 23, 2026. Looking at past instances where RDY's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

RDY moved above its 50-day moving average on February 03, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RDY advanced for three days, in of 336 cases, the price rose further within the following month. The odds of a continued upward trend are .

RDY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. RDY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.796) is normal, around the industry mean (29.792). P/E Ratio (18.428) is within average values for comparable stocks, (74.095). Projected Growth (PEG Ratio) (3.657) is also within normal values, averaging (2.035). RDY has a moderately low Dividend Yield (0.007) as compared to the industry average of (0.029). P/S Ratio (3.015) is also within normal values, averaging (116.680).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RDY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock better than average.

View a ticker or compare two or three
RDY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

RDY is expected to report earnings to fall 98.90% to 16 cents per share on May 08

Dr. Reddy's Laboratories Ltd RDY Stock Earnings Reports
Q1'26
Est.
$0.16
Q4'25
Beat
by $14.36
Q3'25
Est.
$0.20
Q2'25
Missed
by $0.01
Q1'25
Beat
by $0.01
The last earnings report on January 21 showed earnings per share of $14.52, beating the estimate of 15 cents. With 244.96K shares outstanding, the current market capitalization sits at 11.35B.
A.I.Advisor
published Dividends

RDY paid dividends on August 06, 2025

Dr. Reddy's Laboratories Ltd RDY Stock Dividends
А dividend of $0.09 per share was paid with a record date of August 06, 2025, and an ex-dividend date of July 25, 2025. Read more...
A.I. Advisor
published General Information

General Information

a developer of pharmaceuticals

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Generic
Address
8-2-337, Road No. 3
Phone
+91 4049002900
Employees
25863
Web
https://www.drreddys.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
WOOD75.100.90
+1.22%
iShares Global Timber & Forestry ETF
KMAR29.520.10
+0.32%
Innovator U.S. Small Cp Pwr Buf ETF -Mar
TAFL25.040.02
+0.07%
AB Tax-Aware Long Municipal ETF
ARKG30.32-0.30
-0.98%
ARK Genomic Revolution ETF
MRAL4.40-0.09
-2.00%
GraniteShares 2x Long MARA Daily ETF

RDY and Stocks

Correlation & Price change

A.I.dvisor tells us that RDY and COLL have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RDY and COLL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDY
1D Price
Change %
RDY100%
+1.47%
COLL - RDY
33%
Poorly correlated
+0.85%
VTRS - RDY
30%
Poorly correlated
N/A
EOLS - RDY
30%
Poorly correlated
-4.28%
LFCR - RDY
29%
Poorly correlated
-6.46%
TAK - RDY
28%
Poorly correlated
-0.34%
More

Groups containing RDY

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDY
1D Price
Change %
RDY100%
+1.47%
Pharmaceuticals: Generic
industry (214 stocks)
22%
Poorly correlated
-0.59%